2025
- Clinical · Sex Differences4 min read
The black box came off hormone therapy today. A 22-year label, built on 63-year-old participants.
The FDA announced today that it will remove the boxed warnings on menopausal hormone therapies for cardiovascular disease, breast cancer and probable dementia.
- Clinical · Sex Differences4 min read
An FDA panel wants the scariest warning on hormone therapy gone. The 2002 study behind it was about different women.
An expert panel convened by the FDA commissioner urged the agency today to remove the boxed warning — the agency's most severe label — from menopausal hormone therapies, beginning with low-dose vaginal estrogen.